Crosstalk between CML cells with HUVECs and BMSCs through exosomes

Crosstalk between CML cells with HUVECs and BMSCs through exosomes

Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm characterized by presence of the BCR-ABL fusion gene which encodes the constitutively active BCR-ABL chimeric protein. Imatinib is first FDA approved first-line BCR-ABL targeting drug for the treatment of newly diagnosed CML cases. Nowa...

Full description

Bibliographic Details
Main Authors: Zafer Cetin, Eyup I. Saygili, Mehmet Yilmaz
Format: Article
Language:English
Published: IMR Press 2020-10-01
Series:Frontiers in Bioscience-Landmark
Subjects:
chronic myeloid leukemia
cml
exosomes
mi-rna
angiogenesis
adhesion
migration
drug resistance
bone marrow mesenchymal stromal cells
bmscs
cml leukemia stem cells
review
Online Access:https://www.imrpress.com/journal/FBL/26/3/10.2741/4901

Internet

https://www.imrpress.com/journal/FBL/26/3/10.2741/4901

Similar Items